MSON - ミソニックス （MISONIX Inc.） ミソニックスMSONのチャート
MSONの企業情報
| symbol | MSON |
|---|---|
| 会社名 | Misonix Inc. （ミソニックス） |
| 分野（sector） | Capital Goods 資本財（工業製品） |
| 産業（industry） | Medical Specialities |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 ミソニックス（MISONIX INC.）は最少量で侵入的な超音波医療機器製品の設計・製造・開発・売買を行う。同製品には脊椎手術過程に使われる｢BoneScalpel｣切削システム、柔かい・硬い腫瘍の乳化・除去のための｢SonaStar｣外科用吸引装置、生存細胞温存手術の時、失活組織及びフィブリン沈着を有効的に取除くための組織の特定辺縁切除術及び傷洗浄サービスを提供する｢SonicOne｣創傷清拭・創面切除用システム、並びにCovidien Ltd.との契約を通じて同社により売買される｢AutoSonix｣超音波切削及び凝固システム等がある。同社はまた、Johnson_Johnsonの子会社Mentor Corporationを通じて、｢Lysonix｣超音波アシスト脂肪吸引装置の売買を行う。平成23年10月19日、同社は実験室・法医学安全製品事業をMystaire Inc.に売却した。 ミソニックスは、米国の超音波手術装置メ―カ―。低侵襲性の超音波手術装置を設計、製造、開発、販売する。製品は背骨や顎顔面の外科手術システムBoneScalpe、腫瘍除去装置SonaStar、創傷クレンジングと切除システムSonicOneなど。また、汚染ガスを濾過する装置やその他大気汚染緩和用の環境対策製品を科学、工業用にも手掛ける。 Misonix, Inc. is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company's history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients. |
| 本社所在地 | 1938 New Highway Farmingdale NY 11735 USA |
| 代表者氏名 | Stavros G. Vizirgianakis Stavros G. Vizirgianakis |
| 代表者役職名 | President Chief Executive Officer Director 社長兼最高経営責任者（CEO） |
| 電話番号 | +1 631-694-9555 |
| 設立年月日 | 1955年 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 1992年 |
| 従業員数 | 118人 |
| url | www.misonix.com |
| nasdaq_url | https://www.nasdaq.com/symbol/mson |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -1.51223 |
| 終値（lastsale） | 19.505 |
| 時価総額（marketcap） | 184168062.975 |
| 時価総額 | 時価総額（百万ドル） 166.74740 |
| 売上高 | 売上高（百万ドル） 36.67983 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 155.76794 |
| 当期純利益 | 当期純利益（百万ドル） -6.04773 |
| 決算概要 | 決算概要 BRIEF: For the fiscal year ended 30 June 2018 Misonix Inc. revenues increased 35% to $36.7M. Net loss before extraordinary items increased from $1.8M to $6M. Revenues reflect United States segment increase of 22% to $20M. Higher net loss reflects Royalty income decrease of 86% to $525K (income) Research and development expenses increase from $1.8M to $4.4M (expense). |
MSONのテクニカル分析
MSONのニュース
Bioventus Completes the Acquisition of Misonix 2021/10/29 12:25:00 Intrado Digital Media
DURHAM, N.C., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, has completed the acquisition of Misonix, Inc. (Misonix), a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that are designed to enhance clinical outcomes, for cash and common stock. Pursuant to the terms of the merger agreement, Misonix has become a wholly owned subsidiary of Bioventus.
BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration 2021/10/18 12:00:00 Intrado Digital Media
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc . (Nasdaq: MSON) (Misonix), today announced an election deadline of 5:00 p.m., New York City Time, on October 25, 2021 (the Election Deadline) for stockholders of Misonix to elect the form of consideration they wish to receive for their shares of Misonix common stock in connection with the proposed merger of Oyster Merger Sub I, Inc., a newly-formed, wholly-owned subsidiary of Bioventus (Merger Sub I), with and into Misonix, immediately followed by the merger of Misonix with and into Oyster Merger Sub II, LLC, another newly-formed, wholly-owned subsidiary of Bioventus (Merger Sub II), pursuant to the Agreement and Plan of Merger (the Merger Agreement), dated as of July 29, 2021, by and among Bioventus, Merger Sub I, Merger Sub II and Misonix (the Mergers). If the Election Deadline is delayed or extended for any reason, Bioventus and Misonix will promptly announce the delay and, when determined, the rescheduled Election Deadline.
Radiofrequency Ablation System Market Size, Share & Trends Analysis Report By Technology, By Product, By Application, And Segment Forecasts, 2021 – 2027 | Ethicon, Arthrex GmbH, Johnson & Johnson, Misonix, SonaCare Medical, Integra LifeSciences Corporat 2021/10/13 07:23:18 OpenPR
The “Radiofrequency Ablation System Market” provides analysis and insights relating to the many factors expected to be rife throughout the forecast amount whereas providing their impacts on the Market’s growth. The increase within the aviation sector is escalating the expansion
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates MSON, RIVE, OSBC, IRT, ISBC; Shareholders are Encouraged to Contact the Firm 2021/10/04 11:00:00 Benzinga
NEW YORK , Oct. 4, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Misonix, Inc. (NASDAQ: MSON ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Bioventus Inc. Under the terms of the agreement, Misonix stockholders may elect to receive either (i) 1.6839 shares of Bioventus class A common stock or (ii) $28.00 in cash, without interest, for each share of Misonix common stock they hold, subject to proration. If you are a Misonix shareholder, click here to learn more about your rights and options . Full story available on Benzinga.com
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Sanderson Farms, Misonix, and Steadfast Apartment REIT on behalf of Stockholders and Encourages Investors to Contact the Firm 2021/10/01 20:51:00 Intrado Digital Media
NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Sanderson Farms, Inc. (NASDAQ: SAFM), Misonix, Inc. (NASDAQ: MSON), and Steadfast Apartment REIT, Inc. (Other OTC: STFR) (STAR). Additional information about each potential action can be found at the link provided.
Bioventus Completes the Acquisition of Misonix 2021/10/29 12:25:00 Intrado Digital Media
DURHAM, N.C., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, has completed the acquisition of Misonix, Inc. (Misonix), a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that are designed to enhance clinical outcomes, for cash and common stock. Pursuant to the terms of the merger agreement, Misonix has become a wholly owned subsidiary of Bioventus.
BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration 2021/10/18 12:00:00 Intrado Digital Media
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc . (Nasdaq: MSON) (Misonix), today announced an election deadline of 5:00 p.m., New York City Time, on October 25, 2021 (the Election Deadline) for stockholders of Misonix to elect the form of consideration they wish to receive for their shares of Misonix common stock in connection with the proposed merger of Oyster Merger Sub I, Inc., a newly-formed, wholly-owned subsidiary of Bioventus (Merger Sub I), with and into Misonix, immediately followed by the merger of Misonix with and into Oyster Merger Sub II, LLC, another newly-formed, wholly-owned subsidiary of Bioventus (Merger Sub II), pursuant to the Agreement and Plan of Merger (the Merger Agreement), dated as of July 29, 2021, by and among Bioventus, Merger Sub I, Merger Sub II and Misonix (the Mergers). If the Election Deadline is delayed or extended for any reason, Bioventus and Misonix will promptly announce the delay and, when determined, the rescheduled Election Deadline.
Radiofrequency Ablation System Market Size, Share & Trends Analysis Report By Technology, By Product, By Application, And Segment Forecasts, 2021 – 2027 | Ethicon, Arthrex GmbH, Johnson & Johnson, Misonix, SonaCare Medical, Integra LifeSciences Corporat 2021/10/13 07:23:18 OpenPR
The “Radiofrequency Ablation System Market” provides analysis and insights relating to the many factors expected to be rife throughout the forecast amount whereas providing their impacts on the Market’s growth. The increase within the aviation sector is escalating the expansion
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates MSON, RIVE, OSBC, IRT, ISBC; Shareholders are Encouraged to Contact the Firm 2021/10/04 11:00:00 Benzinga
NEW YORK , Oct. 4, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Misonix, Inc. (NASDAQ: MSON ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Bioventus Inc. Under the terms of the agreement, Misonix stockholders may elect to receive either (i) 1.6839 shares of Bioventus class A common stock or (ii) $28.00 in cash, without interest, for each share of Misonix common stock they hold, subject to proration. If you are a Misonix shareholder, click here to learn more about your rights and options . Full story available on Benzinga.com
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Sanderson Farms, Misonix, and Steadfast Apartment REIT on behalf of Stockholders and Encourages Investors to Contact the Firm 2021/10/01 20:51:00 Intrado Digital Media
NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Sanderson Farms, Inc. (NASDAQ: SAFM), Misonix, Inc. (NASDAQ: MSON), and Steadfast Apartment REIT, Inc. (Other OTC: STFR) (STAR). Additional information about each potential action can be found at the link provided.
Bioventus Completes the Acquisition of Misonix 2021/10/29 12:25:00 Intrado Digital Media
DURHAM, N.C., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, has completed the acquisition of Misonix, Inc. (Misonix), a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that are designed to enhance clinical outcomes, for cash and common stock. Pursuant to the terms of the merger agreement, Misonix has become a wholly owned subsidiary of Bioventus.
BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration 2021/10/18 12:00:00 Intrado Digital Media
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc . (Nasdaq: MSON) (Misonix), today announced an election deadline of 5:00 p.m., New York City Time, on October 25, 2021 (the Election Deadline) for stockholders of Misonix to elect the form of consideration they wish to receive for their shares of Misonix common stock in connection with the proposed merger of Oyster Merger Sub I, Inc., a newly-formed, wholly-owned subsidiary of Bioventus (Merger Sub I), with and into Misonix, immediately followed by the merger of Misonix with and into Oyster Merger Sub II, LLC, another newly-formed, wholly-owned subsidiary of Bioventus (Merger Sub II), pursuant to the Agreement and Plan of Merger (the Merger Agreement), dated as of July 29, 2021, by and among Bioventus, Merger Sub I, Merger Sub II and Misonix (the Mergers). If the Election Deadline is delayed or extended for any reason, Bioventus and Misonix will promptly announce the delay and, when determined, the rescheduled Election Deadline.
Radiofrequency Ablation System Market Size, Share & Trends Analysis Report By Technology, By Product, By Application, And Segment Forecasts, 2021 – 2027 | Ethicon, Arthrex GmbH, Johnson & Johnson, Misonix, SonaCare Medical, Integra LifeSciences Corporat 2021/10/13 07:23:18 OpenPR
The “Radiofrequency Ablation System Market” provides analysis and insights relating to the many factors expected to be rife throughout the forecast amount whereas providing their impacts on the Market’s growth. The increase within the aviation sector is escalating the expansion
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates MSON, RIVE, OSBC, IRT, ISBC; Shareholders are Encouraged to Contact the Firm 2021/10/04 11:00:00 Benzinga
NEW YORK , Oct. 4, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Misonix, Inc. (NASDAQ: MSON ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Bioventus Inc. Under the terms of the agreement, Misonix stockholders may elect to receive either (i) 1.6839 shares of Bioventus class A common stock or (ii) $28.00 in cash, without interest, for each share of Misonix common stock they hold, subject to proration. If you are a Misonix shareholder, click here to learn more about your rights and options . Full story available on Benzinga.com
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Sanderson Farms, Misonix, and Steadfast Apartment REIT on behalf of Stockholders and Encourages Investors to Contact the Firm 2021/10/01 20:51:00 Intrado Digital Media
NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Sanderson Farms, Inc. (NASDAQ: SAFM), Misonix, Inc. (NASDAQ: MSON), and Steadfast Apartment REIT, Inc. (Other OTC: STFR) (STAR). Additional information about each potential action can be found at the link provided.